250 related articles for article (PubMed ID: 22208499)
21. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
22. STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
McWilliams IL; Rajbhandari R; Nozell S; Benveniste E; Harrington LE
J Neuroinflammation; 2015 Jun; 12():128. PubMed ID: 26123499
[TBL] [Abstract][Full Text] [Related]
23. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.
Bell JJ; Divekar RD; Ellis JS; Cascio JA; Haymaker CL; Jain R; Tartar DM; Hoeman CM; Hardaway JC; Zaghouani H
J Immunol; 2008 Feb; 180(3):1508-16. PubMed ID: 18209046
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
[TBL] [Abstract][Full Text] [Related]
25. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
[TBL] [Abstract][Full Text] [Related]
26. B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE.
Su Y; Zhang AH; Li X; Owusu-Boaitey N; Skupsky J; Scott DW
Clin Immunol; 2011 Sep; 140(3):260-7. PubMed ID: 21546313
[TBL] [Abstract][Full Text] [Related]
27. Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
Gong Y; Wang Z; Liang Z; Duan H; Ouyang L; Yu Q; Xu Z; Shen G; Weng X; Wu X
PLoS One; 2012; 7(10):e47435. PubMed ID: 23077616
[TBL] [Abstract][Full Text] [Related]
28. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
[TBL] [Abstract][Full Text] [Related]
29. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
30. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
[TBL] [Abstract][Full Text] [Related]
31. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
Faber H; Kurtoic D; Krishnamoorthy G; Weber P; Pütz B; Müller-Myhsok B; Weber F; Andlauer TFM
Front Immunol; 2020; 11():2165. PubMed ID: 33072080
[TBL] [Abstract][Full Text] [Related]
32. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
Miller SD; Gerety SJ; Kennedy MK; Peterson JD; Trotter JL; Tuohy VK; Waltenbaugh C; Dal Canto MC; Lipton HL
J Neuroimmunol; 1990 Jan; 26(1):9-23. PubMed ID: 1688446
[TBL] [Abstract][Full Text] [Related]
33. Experimental autoimmune encephalomyelitis.
Rao P; Segal BM
Methods Mol Med; 2004; 102():363-75. PubMed ID: 15286395
[TBL] [Abstract][Full Text] [Related]
34. Active Induction of Experimental Autoimmune Encephalomyelitis (EAE) with MOG
Giralt M; Molinero A; Hidalgo J
Methods Mol Biol; 2018; 1791():227-232. PubMed ID: 30006713
[TBL] [Abstract][Full Text] [Related]
35. B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.
Zhang AH; Li X; Onabajo OO; Su Y; Skupsky J; Thomas JW; Scott DW
J Autoimmun; 2010 Sep; 35(2):107-13. PubMed ID: 20579844
[TBL] [Abstract][Full Text] [Related]
36. Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in mice.
Tselios T; Aggelidakis M; Tapeinou A; Tseveleki V; Kanistras I; Gatos D; Matsoukas J
Molecules; 2014 Nov; 19(11):17968-84. PubMed ID: 25375337
[TBL] [Abstract][Full Text] [Related]
37. Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system.
Carrillo-Vico A; Leech MD; Anderton SM
J Immunol; 2010 Mar; 184(6):2839-46. PubMed ID: 20164413
[TBL] [Abstract][Full Text] [Related]
38. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
Vandenbark AA; Vainiene M; Ariail K; Miller SD; Offner H
J Neurosci Res; 1996 Aug; 45(4):430-8. PubMed ID: 8872903
[TBL] [Abstract][Full Text] [Related]
39. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
[TBL] [Abstract][Full Text] [Related]
40. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
